ArticleAmerican journal of respiratory and critical care medicine2023

Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks.

Surinder S Birring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.